+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Precision Medicine Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • PDF Icon

    Report

  • 109 Pages
  • October 2021
  • Region: Global
  • Acute Market Reports
  • ID: 5612513
This report titled precision medicine market studies various technology type, application type and geographical scenario. In July 2021, The White House announced that it is giving out USD 55.0 million to a collection of hospitals and companies to uncover links between a person’s genome and disease and built a genetic database of initially at least 1 million Americans. Market experts suggest that the proposed initiative has two main components: a near-term focus on cancers and a longer-term aim to generate knowledge applicable to the whole range of health and disease. Both components are now within the reach because of advances in basic research, including molecular biology, genomics, and bioinformatics.

For the purpose of this study, the global precision medicine market on the basis of technology type is segmented into companion diagnostics, gene sequencing, drug discovery, big data analytics, bio informatics & 3D printing. Market size estimates and forecast for these segments for the period 2019 to 2029 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2021 to 2029, considering 2020 as the base year.

For the purpose of this study, the global precision medicine market on the basis of application type is segmented into oncology, cardiovascular diseases, central nervous system, infectious diseases & others. Market size estimates and forecast for these segments for the period 2019 to 2029 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2021 to 2029, considering 2020 as the base year.

The precision medicine market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2019 to 2029 and their CAGRs for the period 2021 to 2029 are provided in this report.

The major key players profiled in the precision medicine market are on the basis of various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The key players profiled in this report are Biocrates Life Sciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Ferrer InCode, Abbott Laboratories, Almac Group, Ltd., bioMérieux SA, Covance, Silicon Biosystems (now part of the Menarini Group), Pfizer, Eagle Genomics, Source Precision Medicine, Inc., Laboratory Corporation of America Holdings, Medtronics, Novartis, Qiagen, Quest Diagnostics, Roche Holding, Teva Pharmaceuticals, and others.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1 Preface 10
1.1 Report Description 10
1.1.1 Purpose of the Report 10
1.1.2 Target Audience 10
1.1.3 USP and Key Offerings 10
1.2 Research Scope 11
1.3 Research Methodology 12
1.3.1 Phase I - Secondary Research 12
1.3.2 Phase II - Primary Research 13
1.3.3 Phase III - Expert Panel Review 13
1.3.4 Assumptions 14
Chapter 2 Executive Summary 15
2.1 Global Precision Medicine Market, by Technology Type, 2019 v/s 2029 (Value %) 16
2.2 Global Precision Medicine Market, by Application Type, 2020 (USD Mn) 17
2.3 Global Precision Medicine Market, by Geography, 2020 (Value %) 17
Chapter 3 Global Precision Medicine Market Overview 20
3.1 Overview 20
3.2 Market Drivers 20
3.3 Market Restraints 22
3.4 Market Opportunities 23
3.5 Attractive Investment Proposition 23
3.6 Market Competition Assessment: Precision Medicine, by Key Players 25
Chapter 4 Global Precision Medicine Market Analysis, By Technology Type 27
4.1 Overview 27
4.2 Companion Diagnostics 28
4.3 Gene Sequencing 29
4.4 Drug Discovery 31
4.5 Big Data Analytics 32
4.6 Bio Informatics 33
4.7 3D Printing 35
Chapter 5 Global Precision Medicine Market Analysis, By Applications 37
5.1 Overview 37
5.2 Oncology 38
5.3 Cardiovascular Diseases 39
5.4 Central Nervous System 40
5.5 Infectious Diseases 40
5.6 Others Diseases 40
Chapter 6 Global Precision Medicine ion Market, By Geography 42
6.1 Preface 42
6.2 North America 43
6.3 Europe 44
6.4 Asia Pacific 46
6.5 Latin America 47
6.6 Middle East and Africa 49
Chapter 7 Company Profiles 51
7.1 Biocrates Life Sciences 51
7.1.1 Biocrates Life Sciences: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 51
7.2 Nanostring Technologies 52
7.2.1 Nanostring Technologies: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 52
7.3 Tepnel Pharma Services 53
7.3.1 Tepnel Pharma Services: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 53
7.4 Intomics, Ferrer InCode 54
7.4.1 Intomics, Ferrer InCode: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 54
7.5 Abbott Laboratories 55
7.5.1 Abbott Laboratories: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 55
7.6 Almac Group, Ltd. 57
7.6.1 Almac Group, Ltd.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 57
7.7 bioMérieux SA 58
7.7.1 bioMérieux SA: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 58
7.8 Covance 59
7.8.1 Covance: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 59
7.9 Menarini Group 60
7.9.1 Menarini Group: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 60
7.10 Pfizer 61
7.10.1 Pfizer: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 61
7.11 Eagle Genomics, Source Precision Medicine, Inc. 63
7.11.1 Eagle Genomics, Source Precision Medicine, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 63
7.12 Laboratory Corporation of America Holdings 64
7.12.1 Laboratory Corporation of America Holdings: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 64
7.13 Medtronics 65
7.13.1 Medtronics: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 65
7.14 Novartis 66
7.14.1 Novartis: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 66
7.15 Qiagen 67
7.15.1 Qiagen: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 67
7.16 Quest Diagnostics 67
7.16.1 Quest Diagnostics: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 67
7.17 Roche Holding 67
7.17.1 Roche Holding: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 67
7.18 Teva Pharmaceuticals 68
7.18.1 Teva Pharmaceuticals: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 68

Companies Mentioned

  • Biocrates Life Sciences
  • Nanostring Technologies
  • Tepnel Pharma Services
  • Intomics
  • Ferrer InCode
  • Abbott Laboratories
  • Almac Group Ltd.
  • bioMérieux SA
  • Covance
  • Silicon Biosystems (now part of the Menarini Group)
  • Pfizer
  • Eagle Genomics
  • Source Precision Medicine Inc.
  • Laboratory Corporation of America Holdings
  • Medtronics
  • Novartis
  • Qiagen
  • Quest Diagnostics
  • Roche Holding
  • Teva Pharmaceuticals